Contemporary OB/GYN Online CME Activity
Transdermal HRT: New Trends, Emerging Targets
PreviousCover | A B CD E | Session 1 | Session 2 | Session 3 | Post-Test and CME CreditNext
 

Faculty Conflict of Interest Information

It is the policy of MER to ensure balance, independence, objectivity, and scientific rigor in all its education activities. Faculty participating in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations.

Faculty Disclosures

Sarah L. Berga, MD, CHAIR
Professor and Director, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, and Psychiatry, University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pittsburgh, Pa.
Dr. Berga is receives grants from the NIH, American Cancer Society, Jewish Healthcare Foundation, Parke-Davis, Organon, and Insmed. She also is a consultant to the Medical Advisory Board of the International Dairy Foods Association and to WomenFirst Healthcare, Inc.

James H. Liu, MD
Director and Professor, Division of Reproductive Endocrinology and Infertility, University of Cincinnati, Cincinnati, Ohio. Dr. Liu serves on the speakers bureau for Berlex Laboratories.

Lee P. Shulman, MD,
Professor of Obstetrics and Gynecology and Molecular Genetics, Deputy Head, Department of Obstetrics and Gynecology, and Director, Division of Reproductive Genetics, University of Illinois at Chicago. Dr. Shulman receives grants and research support from Berlex Laboratories and Pharmacia and is a consultant for Berlex Laboratories, Pharmacia, Ortho-McNeil, and Pfizer. He serves on the speakers bureau for Berlex Laboratories, Pharmacia, and Ortho-McNeil.

 
PreviousNext